These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 23612570)
1. The role of oxidative and nitrosative bursts caused by azoles and amphotericin B against the fungal pathogen Cryptococcus gattii. Ferreira GF; Baltazar Lde M; Santos JR; Monteiro AS; Fraga LA; Resende-Stoianoff MA; Santos DA J Antimicrob Chemother; 2013 Aug; 68(8):1801-11. PubMed ID: 23612570 [TBL] [Abstract][Full Text] [Related]
2. Dynamic interaction between fluconazole and amphotericin B against Cryptococcus gattii. Santos JR; Gouveia LF; Taylor EL; Resende-Stoianoff MA; Pianetti GA; César IC; Santos DA Antimicrob Agents Chemother; 2012 May; 56(5):2553-8. PubMed ID: 22290956 [TBL] [Abstract][Full Text] [Related]
3. Cryptococcus gattii: in vitro susceptibility to photodynamic inactivation. Soares BM; Alves OA; Ferreira MV; Amorim JC; Sousa GR; Silveira Lde B; Prates RA; Avila TV; Baltazar Lde M; de Souza Dda G; Santos DA; Modolo LV; Cisalpino PS; Pinotti M Photochem Photobiol; 2011; 87(2):357-64. PubMed ID: 21114500 [TBL] [Abstract][Full Text] [Related]
4. Melanin protects Paracoccidioides brasiliensis from the effects of antimicrobial photodynamic inhibition and antifungal drugs. Baltazar LM; Werneck SM; Soares BM; Ferreira MV; Souza DG; Pinotti M; Santos DA; Cisalpino PS Antimicrob Agents Chemother; 2015 Jul; 59(7):4003-11. PubMed ID: 25896704 [TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs. Tay ST; Tanty Haryanty T; Ng KP; Rohani MY; Hamimah H Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448 [TBL] [Abstract][Full Text] [Related]
6. Induction of Mitochondrial Reactive Oxygen Species Production by Itraconazole, Terbinafine, and Amphotericin B as a Mode of Action against Aspergillus fumigatus. Shekhova E; Kniemeyer O; Brakhage AA Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848005 [TBL] [Abstract][Full Text] [Related]
7. Cerebral infection caused by Cryptococcus gattii: a case report and antifungal susceptibility testing. Soares BM; Santos DA; Kohler LM; da Costa César G; de Carvalho IR; dos Anjos Martins M; Cisalpino PS Rev Iberoam Micol; 2008 Dec; 25(4):242-5. PubMed ID: 19071894 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of heat-shock protein 90 enhances the susceptibility to antifungals and reduces the virulence of Cryptococcus neoformans/Cryptococcus gattii species complex. Cordeiro RA; Evangelista AJJ; Serpa R; Marques FJF; Melo CVS; Oliveira JS; Franco JDS; Alencar LP; Bandeira TJPG; Brilhante RSN; Sidrim JJC; Rocha MFG Microbiology (Reading); 2016 Feb; 162(2):309-317. PubMed ID: 26645478 [TBL] [Abstract][Full Text] [Related]
10. Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts. Spadari CC; Vila T; Rozental S; Ishida K Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844051 [No Abstract] [Full Text] [Related]
11. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen. Nishikawa H; Fukuda Y; Mitsuyama J; Tashiro M; Tanaka A; Takazono T; Saijo T; Yamamoto K; Nakamura S; Imamura Y; Miyazaki T; Kakeya H; Yamamoto Y; Yanagihara K; Mukae H; Kohno S; Izumikawa K J Antimicrob Chemother; 2017 Jun; 72(6):1709-1713. PubMed ID: 28201509 [TBL] [Abstract][Full Text] [Related]
12. Thiazole compounds with activity against Cryptococcus gattii and Cryptococcus neoformans in vitro. Pereira de Sá N; Lino CI; Fonseca NC; Borelli BM; Ramos JP; Souza-Fagundes EM; Rosa CA; Santos DA; Barbosa de Oliveira R; Johann S Eur J Med Chem; 2015 Sep; 102():233-42. PubMed ID: 26276437 [TBL] [Abstract][Full Text] [Related]
13. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559 [TBL] [Abstract][Full Text] [Related]
14. Antifungal activity of eicosanoic acids isolated from the endophytic fungus Mycosphaerella sp. against Cryptococcus neoformans and C. gattii. Pereira CB; Pereira de Sá N; Borelli BM; Rosa CA; Barbeira PJS; Cota BB; Johann S Microb Pathog; 2016 Nov; 100():205-212. PubMed ID: 27693577 [TBL] [Abstract][Full Text] [Related]
15. Central nervous system infection due to Cryptococcus gattii sensu lato in India: Analysis of clinical features, molecular profile and antifungal susceptibility. Lahiri Mukhopadhyay S; Bahubali VH; Manjunath N; Swaminathan A; Maji S; Palaniappan M; Parthasarathy S; Chandrashekar N Mycoses; 2017 Nov; 60(11):749-757. PubMed ID: 28736880 [TBL] [Abstract][Full Text] [Related]
16. Astemizole and an analogue promote fungicidal activity of fluconazole against Cryptococcus neoformans var. grubii and Cryptococcus gattii. Vu K; Gelli A Med Mycol; 2010 Mar; 48(2):255-62. PubMed ID: 19572230 [TBL] [Abstract][Full Text] [Related]
17. Heterocycle Thiazole Compounds Exhibit Antifungal Activity through Increase in the Production of Reactive Oxygen Species in the Cryptococcus neoformans-Cryptococcus gattii Species Complex. Sá NP; Lima CM; Lino CI; Barbeira PJS; Baltazar LM; Santos DA; Oliveira RB; Mylonakis E; Fuchs BB; Johann S Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533240 [TBL] [Abstract][Full Text] [Related]
18. Long-term surveillance and treatment of subclinical cryptococcosis and nasal colonization by Cryptococcus neoformans and C. gattii species complex in captive koalas (Phascolarctes cinereus). Kido N; Makimura K; Kamegaya C; Shindo I; Shibata E; Omiya T; Yamamoto Y Med Mycol; 2012 Apr; 50(3):291-8. PubMed ID: 21859391 [TBL] [Abstract][Full Text] [Related]
19. Antimalarials and amphotericin B interact synergistically and are new options to treat cryptococcosis. Freitas GJC; Ribeiro NQ; Gouveia-Eufrasio L; Emidio ECP; Guimarães GM; César IC; Paixão TA; Oliveira JBS; Caza M; Kronstad JW; Santos DA Int J Antimicrob Agents; 2023 Jul; 62(1):106807. PubMed ID: 37030471 [TBL] [Abstract][Full Text] [Related]
20. Susceptibility to antifungal agents and genotypes of Brazilian clinical and environmental Cryptococcus gattii strains. Silva DC; Martins MA; Szeszs MW; Bonfietti LX; Matos D; Melhem MS Diagn Microbiol Infect Dis; 2012 Apr; 72(4):332-9. PubMed ID: 22341512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]